EBR:IBAB - Euronext Brussels - BE0003766806 - Common Stock - Currency: EUR
EBR:IBAB (3/7/2025, 7:00:00 PM)
13.02
-0.06 (-0.46%)
The current stock price of IBAB.BR is 13.02 EUR. In the past month the price decreased by -3.41%. In the past year, price increased by 16.25%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28.81 | 214.85B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 1,844 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
ION BEAM APPLICATIONS
Chemin du Cyclotron 3
Louvain-la-Neuve BRABANT-WALLON BE
Employees: 1943
Company Website: https://iba-worldwide.com
Investor Relations: http://www.iba-worldwide.com/investor-relations/publications
Phone: 3210475811
The current stock price of IBAB.BR is 13.02 EUR. The price decreased by -0.46% in the last trading session.
The exchange symbol of ION BEAM APPLICATIONS is IBAB and it is listed on the Euronext Brussels exchange.
IBAB.BR stock is listed on the Euronext Brussels exchange.
10 analysts have analysed IBAB.BR and the average price target is 17.42 EUR. This implies a price increase of 33.77% is expected in the next year compared to the current price of 13.02. Check the ION BEAM APPLICATIONS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ION BEAM APPLICATIONS (IBAB.BR) has a market capitalization of 394.25M EUR. This makes IBAB.BR a Small Cap stock.
ION BEAM APPLICATIONS (IBAB.BR) currently has 1943 employees.
ION BEAM APPLICATIONS (IBAB.BR) has a support level at 12.92 and a resistance level at 13.22. Check the full technical report for a detailed analysis of IBAB.BR support and resistance levels.
The Revenue of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 13.58% in the next year. Check the estimates tab for more information on the IBAB.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 0.91%. The yearly dividend amount is currently 0.21. Check the full fundamental report for a detailed analysis of IBAB.BR dividend history, reliability and sustainability.
ION BEAM APPLICATIONS (IBAB.BR) will report earnings on 2025-03-20, after the market close.
The PE ratio for ION BEAM APPLICATIONS (IBAB.BR) is 48.22. This is based on the reported non-GAAP earnings per share of 0.27 and the current share price of 13.02 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IBAB.BR.
ChartMill assigns a technical rating of 1 / 10 to IBAB.BR. When comparing the yearly performance of all stocks, IBAB.BR turns out to be only a medium performer in the overall market: it outperformed 65.89% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. IBAB.BR has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.27. The EPS increased by 139.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.69% | ||
ROA | 1.32% | ||
ROE | 8.7% | ||
Debt/Equity | 0.32 |
ChartMill assigns a Buy % Consensus number of 80% to IBAB.BR. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 149.04% and a revenue growth 13.58% for IBAB.BR